Location Nottingham, United Kingdom, Europe Regions Europe, Middle East, and Africa (EMEA) Gender Male Also Known As Nick Ash
Website www.biofortuna.com/about/management-team/ LinkedIn View on LinkedIn
Nick is an experienced CEO with over 20 years’experience in public listed and private companies operating internationally across the life sciences, healthcare diagnostic and biotechnology industries. Prior to joining Biofortuna, Nick was CEO of Source BioScience plc, the laboratory service and products business, where he helped grow revenues five
fold, delivering an enterprise valued at more than £70 million. Nick holds a PhD in Mycology and is a Chartered Accountant, qualifying with KPMG. Nick is currently Chairman of Epistem Limited, the pre-clinical and clinical development CRO.
